Originally developed for type 2 diabetes, these medications (like semaglutide and tirzepatide) help regulate blood sugar, reduce appetite, and support meaningful, sustained weight loss
Neurodegenerative diseases including multiple sclerosis, Parkinson's disease, and Alzheimer's disease show preliminary preclinical evidence of BPC-157 benefits
Stomach upset- Stomach upset, vomiting and nausea are common side effects of these kinds of medication
Structure-function studies and mechanism of action of snake venom L-amino acid oxidases
SGLT2 [sodium-glucose cotransporter 2] inhibitors initially seemed to be linked with an even lower risk of uveitis compared to GLP-1 receptor agonists, but after doing a sensitivity analysis of patients on monotherapy, we no longer found that association